Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies

Journal of Hypertension

Volumn 14, Issue 6, 1996, Pages 719-727

  Danilov, Sergei ^a,b   Savoie, Françoise ^a,b   Lenoir, Bertrand ^a,b   Jeunemaitre, Xavier ^a,b   Azizi, Michel ^a,b   Tarnow, Lise ^c   Alhenc Gelas, François ^a,b  

^a INSERM   (France)

^b HÔPITAL BROUSSAIS   (France)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

Angiotensin converting enzyme; Genetic polymorphism; Immunoassay; Monoclonal antibodies

Indexed keywords

ALKALINE PHOSPHATASE; DIPEPTIDYL CARBOXYPEPTIDASE; LEUCINE; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; DNA POLYMORPHISM; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; GOAT; HUMAN; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; RABBIT; TECHNIQUE;

EID: 0029949790     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199606000-00007     Document Type: Article

References (48)

1. Erdös E: Angiotensin I-converting enzyme and the changes in our concept through the years. Hypertension 1991, 16:363-370.
2. Oparil S, Low J, Koerner JJ: Altered angiotensin I-conversion in pulmonary disease. Clin Sci Mol Med 1976, 51:537-543.
3. Lieberman J: Elevation of serum angiotensin-converting enzyme level in sarcoidosis. Am J Med 1975, 59:365-372.
4. Lieberman J, Sastre A: Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 1980, 93:825-826.
5. Cambien F, Alhenc-Gelas F, Herberth B, André JL, Rakotovao R, Gonzales MF, et al.: Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet 1988, 43:774-780.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
7. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al.: Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205.
8. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J 1993, 290:33-40.
9. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
10. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al.: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993, 341:991-992.
11. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzalez MF, et al.: Plasma level and ACE gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994, 90:669-676.
12. Raynolds MV, Bristow MR, Bush AW, Abraham WT, Lowes BD, Zisman LS, et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342:1073-1075.
13. Marian AJ, Yu QT, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993, 342:1073-1075.
14. Shunckert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
15. Bonithon-Kopp C, Ducimetière P, Touboul PJ, Touboul PJ, Fève JM, Billaud E, et al.: Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994, 89:952-954.
16. Payne MN, McDonald F, Murray RG, Barlett WA, Jones AF, Beattie JM, et al.: Plasma angiotensin converting enzyme activity and carotid wall thickening. Circulation 1994, 90:2566-2567.
17. Maree M, Bernadet P, Gallois PY, Savagner F, Guyene TT, Hallab M, et al.: Relationship between angiotensin I-converting enzyme gene polymorphism, plasma level and diabetic retinal and renal complications. Diabetes 1994, 43:384-388.
18. Ruiz J, Blanché H, Cohen N, Velho G, Cambien F, Cohen D, et al.: Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994, 91b:3662-3666.
19. Harden PN, Geddes C, Rowe PA, MacIlroy JH, Boulton-Jones M, Stuart R, et al.: Polymorphisms in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995, 345:1540-1542.
20. Nakai K, Chuichi I, Miura Y, Hotta K, Musha T, Itoh T, et al.: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994, 90:2199-2202.
21. Badenhop RF, Wang XL, Wilcken D: Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995, 91:1655-1658.
22. Mattu RK, Needham E, Galton D, Frangos E, Clark A, Caulfield M: A DNA at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation 1995, 91:270-274.
23. Ludwig E, Corneli P, Anderson J, Marshall HW, Lalouel J-M, Ward RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995, 91:2120-2124.
24. Miettinen H, Korpela K, Hälläinen L, Kontula K: Polymorphisms of the apolipoprotein and angiotensin-converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 1994, 94:189-192.
25. Lindpainter K, Pfeffer M, Krentz R, Stampfer MJ, Grodstein F, la Motte F, et el.: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995, 332:706-711.
26. Alhenc-Gelas F, Weare J, Johnston R, Erdös EG: Measurement of human converting enzyme level by direct radioimmunoassay. J Lab Clin Med 1983, 101:83-96.
27. Hiwada K, Inoue Y, Tanaka Y, Hashimoto A, Akutsu H, Kitatani F, et al.: Direct radioimmunoassay of angiotensin converting enzyme in sera from patient with pulmonary diseases. Lung 1987, 165:27-35.
28. Lancillo Y, Fanburg B: Development of competitive enzyme immunoassay for human serum angiotensin I-converting enzyme, a comparison of four assay configurations. Anal Biochem 1982, 126:156-164.
29. Stevens J, Danilov S, Fanburg BL, Lanzillo JJ: A sensitive two-site sandwich enzyme immunoassay for human angiotensin I-converting enzyme utilizing monoclonal antibodies. J Immunol Meth 1990, 132:263-273.
30. Danilov S, Allikmets E, Sakharov I, Dukhanina E, Trakht I: Monoclonal antibodies to human lung angiotensin-converting enzyme. Biotechnol Appl Biochem 1987, 9:319-322.
31. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, et al.: Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. J Biol Chem 1994, 269:26806-26814.
32. Bruneval P, Hinglais N, Alhenc-Gelas F, Tricottet V, Corvol P, Menard J, et al.: Angiotensin I-converting enzyme in human intestine and kidney. Histochemistry 1986, 85:73-80.
33. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E: Expression and characterisation of recombinant human angiotensin I-converting enzyme. J Biol Chem 1991, 266:5540-5546.
34. Wei L, Alhenc-Gelas F, Corvol P, Clauser E: The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 1991, 266:9002-9008.
35. Cushman DW, Cheung HS: Spectrophotometric assay and properties of the angiotensin enzyme of the rabbit lung. Biochem Pharmacol 1971, 20:1637-1648.
36. Friedland J, Silverstein E: A sensitive fluorimetric assay for serum angiotensin converting enzyme. Am J Clin Pathol 1976, 66:416-424.
37. Piquilloud Y, Reinharz A, Roth M: Studies on the angiotensin converting enzyme with different substrates. Biochim Biophys Acta 1970, 206:136-142.
38. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, et al.: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferate retinopathy in IDDM patients. Diabetes 1995, 44:489-494.
39. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucleic Acids Res 1992, 20:1433.
40. Rodbard D: Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem 1974, 20:1255-1270.
41. Lee EJD: The angiotensin I-converting enzyme genetic polymorphism is associated with altered substrate affinity. Pharmacogenetics 1994, 4:101-103.
42. Erhard MH, Kellner J, Schmidhuber S, Schams D, Lösch U: Identification of antigenic differences of recombinant and pituitary bovine growth hormone using monoclonal antibodies. J Immunoassay 1994, 15:1-19.
43. Feizi T, Childs R: Carbohydrates as antigenic determinants of glycoproteins. Biochem J 1987, 245:1-11.
44. Gustafson R, Proper JA, Bowie EJW, Sommer S: Parameters affecting the yield of DNA from human blood. Anal Biochem 1987, 165:294-299.
45. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P: Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameter. J Lab Clin Med 1991, 117:33-39.
46. Kohse KP, Wisser H: Antibodies as a source of analytical errors. J Clin Chem Clin Biochem 1990, 28:881-892.
47. Boscato LM, Stuart MC: Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986, 32:1491-1495.
48. Thompson RJ, Jackson AP, Langlois N: Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects - incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme. Clin Chem 1986, 32:476-481.